Sellas Life Sciences Surges 156% After Cancer Vaccine Data
Sellas Life Sciences Group Inc. soared after the drug developer reported positive late-stage trial results for an experimental cancer vaccine to treat an aggressive form of blood cancer.

<p>Sellas Life Sciences Group Inc. soared after the drug developer reported positive late-stage trial results for an experimental cancer vaccine to treat an aggressive form of blood cancer.</p>